Your browser doesn't support javascript.
loading
Simvastatin therapy in higher dosages deteriorates bone quality: Consistent evidence from population-wide patient data and interventional mouse studies.
Leutner, Michael; Butylina, Maria; Matzhold, Caspar; Klimek, Peter; Cuhaj, Carina; Bellach, Luise; Baumgartner-Parzer, Sabina; Reiter, Birgit; Preindl, Karin; Kautzky, Alexander; Stimpfl, Thomas; Thurner, Stefan; Pietschmann, Peter; Fürnsinn, Clemens; Kautzky-Willer, Alexandra.
Afiliación
  • Leutner M; Department of Internal Medicine III, Clinical Division of Endocrinology and Metabolism, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
  • Butylina M; Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
  • Matzhold C; Section for Science of Complex Systems, CeMSIIS, Medical University of Vienna, Spitalgasse 23, A-1090, Austria; Complexity Science Hub Vienna, Josefstaedter Straße 39, 1080 Vienna, Austria.
  • Klimek P; Section for Science of Complex Systems, CeMSIIS, Medical University of Vienna, Spitalgasse 23, A-1090, Austria; Complexity Science Hub Vienna, Josefstaedter Straße 39, 1080 Vienna, Austria.
  • Cuhaj C; Department of Internal Medicine III, Clinical Division of Endocrinology and Metabolism, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
  • Bellach L; Department of Internal Medicine III, Clinical Division of Endocrinology and Metabolism, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
  • Baumgartner-Parzer S; Department of Internal Medicine III, Clinical Division of Endocrinology and Metabolism, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
  • Reiter B; Joint Metabolome Facility, University and Medical University of Vienna, Vienna, Austria.
  • Preindl K; Joint Metabolome Facility, University and Medical University of Vienna, Vienna, Austria.
  • Kautzky A; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
  • Stimpfl T; Joint Metabolome Facility, University and Medical University of Vienna, Vienna, Austria; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Thurner S; Section for Science of Complex Systems, CeMSIIS, Medical University of Vienna, Spitalgasse 23, A-1090, Austria; Complexity Science Hub Vienna, Josefstaedter Straße 39, 1080 Vienna, Austria; Santa Fe Institute, Santa Fe, NM 85701, USA.
  • Pietschmann P; Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
  • Fürnsinn C; Department of Internal Medicine III, Clinical Division of Endocrinology and Metabolism, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria. Electronic address: clemens.fuernsinn@meduniwien.ac.at.
  • Kautzky-Willer A; Department of Internal Medicine III, Clinical Division of Endocrinology and Metabolism, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria; Gender Institute, A-3571 Gars am Kamp, Austria. Electronic address: alexandra.kautzky-willer@meduniwien.ac.at.
Biomed Pharmacother ; 158: 114089, 2023 Feb.
Article en En | MEDLINE | ID: mdl-36538862
ABSTRACT

BACKGROUND:

Combining mouse experiments with big data analysis of the Austrian population, we investigated the association between high-dose statin treatment and bone quality.

METHODS:

The bone microarchitecture of the femur and vertebral body L4 was measured in male and ovariectomized female mice on a high-fat diet containing simvastatin (1.2 g/kg). A sex-specific matched big data analysis of Austrian health insurance claims using multiple logistic regression models was conducted (simvastatin 60-80 mg/day vs. controls; males n = 138,666; females n = 155,055).

RESULTS:

High-dose simvastatin impaired bone quality in male and ovariectomized mice. In the trabecular femur, simvastatin reduced bone volume (µm3 ♂, 213 ± 15 vs. 131 ± 7, p < 0.0001; ♀, 66 ± 7 vs. 44 ± 5, p = 0.02) and trabecular number (1/mm ♂, 1.88 ± 0.09 vs. 1.27 ± 0.06, p < 0.0001; ♀, 0.60 ± 0.05 vs. 0.43 ± 0.04, p = 0.01). In the cortical femur, bone volume (mm3 ♂, 1.44 ± 0.03 vs. 1.34 ± 0.03, p = 0.009; ♀, 1.33 ± 0.03 vs. 1.12 ± 0.03, p = 0.0002) and cortical thickness were impaired (µm ♂, 211 ± 4 vs. 189 ± 4, p = 0.0004; ♀, 193 ± 3 vs. 169 ± 3, p < 0.0001). Similar impairments were found in vertebral body L4. Simvastatin-induced changes in weight or glucose metabolism were excluded as mediators of deteriorations in bone quality. Results from mice were supported by a matched cohort analysis showing an association between high-dose simvastatin and increased risk of osteoporosis in patients (♂, OR 5.91, CI 3.17-10.99, p < 0.001; ♀, OR 4.16, CI 2.92-5.92, p < 0.001).

CONCLUSION:

High-dose simvastatin dramatically reduces bone quality in obese male and ovariectomized female mice, suggesting that direct drug action accounts for the association between high dosage and increased risk of osteoporosis as observed in comparable human cohorts. The underlying pathophysiological mechanisms behind this relationship are presently unknown and require further investigation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Osteoporosis / Inhibidores de Hidroximetilglutaril-CoA Reductasas Tipo de estudio: Etiology_studies / Observational_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Biomed Pharmacother Año: 2023 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Osteoporosis / Inhibidores de Hidroximetilglutaril-CoA Reductasas Tipo de estudio: Etiology_studies / Observational_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Biomed Pharmacother Año: 2023 Tipo del documento: Article País de afiliación: Austria
...